CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 80 enrolled
Drug / intervention
Amiodarone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00420017
NCT00420017Phase 4Completed
CompareCT.gov

Prevention of Atrial Fibrillation Following Thoracoabdominal Esophagectomy Surgery

Indiana University·interventional·Posted Jan 9, 2007·Updated Sep 18, 2013

In Brief

A Phase 4 clinical trial evaluating Amiodarone and Control for Atrial Fibrillation and Esophagectomy. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to: Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy surgery; Determine the influence of the prevention of AF following esophagectomy surgery on post-surgical duration of stay in the Intensive Care Unit ICU)and duration of post-surgical hospital stay; and Determine the safety of amiodarone for the prevention of AF following esophagectomy surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Esophagectomy
CountriesUnited States
CollaboratorsPurdue University, Indiana University Health

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 9, 2007
Enrollment StartSep 1, 2005
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 19.5 years ago

Interventions

Amiodaronedrug

Intravenous amiodarone continuous infusion x 4 days

Controlother

No amiodarone